ST. LOUIS, Feb. 21, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announcedtoday it has scheduled an investor day meeting in New York City on May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time)
The presentation will be broadcast via the Internet and can be accessed at the Investor Relations section of Express Scripts' website at http://www.express-scripts.com. RealPlayer or Windows Media Player is needed to listen to the broadcast and free downloads of these players are available at the broadcast site. The broadcast will remain available on the Investor Relations section of Express Scripts' website for 90 days.
About Express Scripts
Express Scripts is leading the way for tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides a full range of integrated pharmacy benefit management services, including home delivery pharmacy care, specialty pharmacy care and benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis, that guide patients and plans toward better health by prioritizing care and increasing savings. Our services drive down the cost of care for employer-funded, Medicare, Medicaid and Public Exchange plans, and create the headroom needed to keep patients' cost-share low, access broad, and do more for those who are challenged by high out-of-pocket costs. Express Scripts also distributes a full range of biopharmaceutical products and offers innovative medical benefit management services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
View original content:http://www.prnewswire.com/news-releases/express-scripts-holding-company-announces-webcast-of-investor-day-meeting-300601921.html
SOURCE Express Scripts
Subscribe to our Free Newsletters!
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...View All